Leadership Team
William Hoos
President
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
William Hoos joined JLF in September 2020 as president. He also serves as vice president of strategy with xCures, he is a venture partner at Pilot Mountain Ventures, and founder and CEO of NQ Oncology. In addition, he advises medical diagnostic, device, pharmaceutical and patient advocate organizations globally on product development and market strategy. His past clients include OncoPlexDx (acquired by NantOmics), Pancreatic Cancer Action Network, Skyline Diagnostics BV and Vanda Pharmaceuticals.
Mr. Hoos was previously with Philips Home Healthcare Solutions (Respironics) as Director of New Product Commercialization, where he led the Sleep Well Ventures business in bringing key new products to market. Sleep Well Ventures was established by Respironics as an internal venture group responsible for creating a portfolio of medical devices through business development, acquisitions, and equity investments. While there, Mr. Hoos led new product marketing, strategy and implementation, applied research, clinical trial design, regulatory strategy, and manufacturing. Mr. Hoos led the international launch of a novel insomnia therapy device and designed and defended the US regulatory approval strategy including multiple meetings with the FDA. Additionally, he led the successful integration of an acquisition in light therapy devices and on-time design and launch of their next generation award-winning product.
Prior to Respironics, Mr. Hoos held various roles in R&D and business development. He has also been a software entrepreneur and founded ClinWiki.org which provides crowd sourced clinical trial information. He serves as an Entrepreneur In Residence at Launch Chapel Hill and on the Board of SECU Family House at UNC Hospitals.
Mr. Hoos earned an MBA from Georgia Institute of Technology. He holds a BS Chemistry from Wake Forest University and MS Organic Chemistry from the University of California, Los Angeles.
Marty Tenenbaum, PhD
Co-founder & Chairman
xCures and Cancer Commons
Marty Tenenbaum, Ph.D., is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons and CollabRx (NASD: CRLX) to help each cancer patient obtain the best possible outcome. He is an Internet commerce pioneer and visionary, having founded EIT (1990) and CommerceNet (1994) to accelerate business use of the Internet, and later, was an officer and director of Commerce One, Webify Solutions (sold to IBM in 2006), and Medstory (sold to Microsoft in 2007). He currently serves on the boards of Efficient Finance, Patients Like Me, and the Public Library of Science (PLoS).
Dr. Tenenbaum is a fellow and former board member of the Association for the Advancement of Artificial Intelligence (AAAI), and a former consulting professor of Computer Science at Stanford. He holds B.S. and M.S. degrees in Electrical Engineering and Computer Science from MIT, and a Ph.D. from Stanford. More at cancercommons.org.
William Gillanders, MD
Professor of Surgery, Division of General Surgery, Section of Endocrine and Oncologic Surgery
Washington University School of Medicine in St. Louis
Malachi Griffith, PhD
Associate Professor of Medicine (Oncology) and Genetics and Assistant Director of the McDonnell Genome Institute, Washington University School of Medicine in St. Louis
Dr. Griffith is Associate Professor of Medicine (Oncology) and Genetics and Assistant Director of the McDonnell Genome Institute at Washington University. Dr. Griffith’s research is focused on the development of personalized medicine strategies for cancer. He develops bioinformatics tools and methods for the analysis of high throughput sequence data to improve our understanding of cancer biology, treatment and mechanisms of resistance. In the past few years, immunogenomics has become a major focus of his research. Dr. Griffith is a co-chair of the Global Alliance for Genomic Health Variant Interpretation for Cancer Consortium. He has published over 90 studies, received numerous research awards and honors and held several large grants from the NIH including a K99/R00 Career Development Award. He has mentored more than 50 bioinformatics trainees and taught more than 500 as an instructor for Cold Spring Harbor Laboratories and the Canadian Bioinformatics Workshops.
Andrew Jacobs
Board Member
ennov1
Andrew Jacobs has devoted 40 years to starting and successfully managing and growing small and medium sized companies, as well as several non-profit organizations. He currently serves as president of Sustainable Agriculture Fund, a small private investment fund he founded in 2011 which provides affordable capital to small and medium sized environmentally sustainable agricultural enterprises. Andy was previously CEO, President and majority shareholder of PCCW Teleservices (US), Inc. (now HKT Teleservices), a multinational call center service provider, sold to premier Hong Kong telecommunications provider HKT. Andy’s initial entrepreneurial effort was to found, lead and successfully sell Excel Retirement Communities, a builder, developer and operator of luxury independent and assisted living facilities. Prior to Excel, Andy was a securities and anti-trust litigator at the New York law firm Davis Polk & Wardwell.
Since his “semi-retirement”, Andy has completed several consulting CEO assignments. From 2020 to January 2022, he was Co-Manager of ennov1 LLC, a start-up company whose mission is to enable cancer patients to gain control of their health data and to use that data to access a wider range of available treatment options (he continues to serve on its Board of Directors), and from 2016 to 2019 was CEO of Upcycle Inc., the developer of a novel, patented process to transform organic waste into usable energy, water and minerals.
Andy’s non-profit efforts include serving on the founding Board of Directors of Civic Influencers (formerly Campus Election Engagement Project) from 2019-2022 and co-founding Urban Farms of Central Ohio, a non-profit organization whose mission was to grow healthy food on abandoned or underutilized urban property. He served on the Board of Harlem Grown, a New York City based youth development and urban farming organization (2013 – 2019, Chairman, 2014 – 2018), and is a member of the Donor Services and Development Advisory Committee of The Columbus Foundation, one of the nation’s top community foundations.
With his wife, Cathy, Andy owns Shaker View Farm, a 200-acre certified organic farm in the Hudson Valley of New York.
Andy is a graduate of Johns Hopkins University and the University of Michigan Law School.
Andrew Popp
CTO and Co-founder
ennov1
Andrew Popp is a lifelong technologist and professional systems engineer who has made a career working in complex on-prem and cloud environments.
During the course of his eight-year career, Andrew has implemented advanced approaches to technical problems resulting in operational excellence and increased business performance. His experience across several tech-industry verticals SaaS, e-commerce, and digital advertising have provided him with the technical skills and business acumen to push technology forward, create technology culture, and keep non-technical stakeholders fully involved in the technical process.
Andrew has previously worked at Wayfair, ServiceChannel Inc, and Ogilvy and Mather. He received a BA from Colby-Sawyer College, New London NH.
Jason Chang
CEO and Chairman
CSBio
Jason Chang is the Chief Executive Officer and Chairman of CSBio, a life science company focused on clinical and commercial drug substance manufacturing for new therapeutic peptides.
Chang has more than 10 years of experience as a senior executive and has played an integral role in the growth of CSBio. He oversees key company initiatives in both science and new business verticals. In 2017, the FDA qualified CSBio’s cGMP facility for commercial production. In order to better serve personalized oncology clinical trials and the greater life science industry, Chang is focused on expanding to a second cGMP facility in Milpitas and receiving entitlements to develop a life science incubator in Menlo Park.
Chang has a passion for cars and motorcycles and is often found at the racetrack. He is also a Board Member of the Rector’s Council at Lincoln College (University of Oxford).
A native of the Bay Area, Chang earned his Bachelor of Arts Economics degree at the University of California, San Diego in 2002 and his Master in Biochemistry degree from the University of Oxford in 2009.